Seed VC · USA
The longevity field will achieve breakthrough in this decade by getting the first approved longevity drugs for age-related diseases into patients and the clinic, driven by mission-oriented, unconventional founders building founder-led companies they largely control.
Business models
biotech_therapeutics
Customer segments
Researchers, Patients
Geography
US
We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.
The Longevity Fund writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks The Longevity Fund alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Seed VC
Asha Ventures
DeepTech, Healthtech, Food & Ag
Seed VC
Asimov Ventures
DeepTech, AI, Industry 4.0 / Robotics
Seed VC
Assembly Climate Capital
DeepTech, Energy, Food & Ag
Seed VC
Assembly Ventures
DeepTech, AI, Energy
Seed VC
Aster Capital
DeepTech, Industry 4.0 / Robotics, Energy
Seed VC
Astera Institute
DeepTech, Aerospace, Biotech
Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. The Longevity Fund is one of them, and we'll tell you exactly where they sit in your top 100.